Significant Pharmaceuticals Reported in US Patents

Significant Pharmaceuticals Reported in US Patents identifies the next generation of pharmaceuticals reported in US Patents. This "hands-on" title provides explicit laboratory methods for preparing the most recent and effective medications. Each entry documents the biological testing protocols used to evaluate a drug and the significance of the current treatment agent over previous methods. Pharmaceuticals are included in this review only if at least two of the following criteria were met: Effectiveness in treating an illness, Innovative, ease of preparation, synergy with existing Medications.

Pharmaceuticals are reported for 27 separate classes of illness, including: AIDS, Alzheimer's Disease, Cardiovascular Disorders, Diabetes, Epilepsy, Hepatitis C, Osteoporosis, Obesity and Sleep Disorders.

Significant Pharmaceuticals Reported in US Patents has been designed to be used as both a reference and synthetic guide for pharmaceutical, medicinal and organic chemists and graduate students.

Researchers working in other areas will also find the information valuable as in many instances intermediates or the next generation pharmaceutical are readily convertible into other industrial products including: anti-oxidants, chemical additives, herbicides, polymer precursors, water purification agents. Clear structural depictions of reagents and chemical transformations have been supplied to permit the identification of other future applications.

Acquired Immune Deficiency Syndrome
Addiction Disorders
Alzheimer's Disease
Analgesics
Antibacterial Agents
Anti-inflammatory Agents
Autoimmune Disorders
Cardiovascular Disorders
Diabetes
Diagnostics
Epilepsy
Gastrointestional Disorders
Hepatitis C
Hormonal Disorders
Immunosuppressants
Improved Synthetic Methods
Incontinence
Irritable Bowel Syndrome
Osteoporosis
Malaria
Migraine Headaches
Obesity
Proliferative Disorders
Skin Disorders
Sleep Disorders
Thyroid Disorders
Tinnitus